Call Options

29 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $29.4 Million - $35.7 Million
-179,300 Reduced 27.9%
463,300 $91.5 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $12.8 Million - $14.9 Million
82,700 Added 14.77%
642,600 $110 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $99.1 Million - $113 Million
-619,900 Reduced 52.54%
559,900 $102 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $10.3 Million - $11.6 Million
75,000 Added 6.79%
1,179,800 $183 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $14.3 Million - $16.6 Million
107,200 Added 10.75%
1,104,800 $165 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $11.9 Million - $14.8 Million
89,600 Added 9.87%
997,600 $134 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $46.4 Million - $53.4 Million
320,800 Added 54.63%
908,000 $145 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $27.2 Million - $32.6 Million
196,600 Added 50.33%
587,200 $95 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $18.1 Million - $20.8 Million
-135,100 Reduced 25.7%
390,600 $52.4 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $16.7 Million - $21.2 Million
-121,200 Reduced 18.74%
525,700 $80.5 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $38.9 Million - $48.3 Million
295,100 Added 83.88%
646,900 $105 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $7.54 Million - $9.54 Million
70,200 Added 24.93%
351,800 $47.6 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $16 Million - $18.2 Million
-150,600 Reduced 34.84%
281,600 $30.4 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $11.5 Million - $12.8 Million
109,600 Added 33.97%
432,200 $48.7 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $29.8 Million - $32.8 Million
-291,400 Reduced 47.46%
322,600 $34.9 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $7.48 Million - $10.1 Million
92,900 Added 17.83%
614,000 $65.8 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $32.3 Million - $37.9 Million
-375,600 Reduced 41.89%
521,100 $45.6 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $47.7 Million - $63.8 Million
650,000 Added 263.48%
896,700 $88 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $39.8 Million - $60.3 Million
-616,300 Reduced 71.41%
246,700 $18.8 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $40 Million - $50 Million
554,100 Added 179.38%
863,000 $76.4 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $14.7 Million - $17.7 Million
234,000 Added 312.42%
308,900 $23.4 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $1.77 Million - $2.26 Million
26,900 Added 56.04%
74,900 $5.45 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $22.2 Million - $26.2 Million
-288,400 Reduced 85.73%
48,000 $3.87 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $7.61 Million - $9.39 Million
-97,800 Reduced 22.52%
336,400 $31 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $18.4 Million - $20.4 Million
206,500 Added 90.69%
434,200 $41.1 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $987,580 - $1.17 Million
-11,000 Reduced 4.61%
227,700 $21.1 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $570,462 - $763,902
-6,200 Reduced 2.53%
238,700 $22.6 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $16.8 Million - $18.5 Million
-188,100 Reduced 43.44%
244,900 $23.7 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $30.2 Million - $38.6 Million
433,000
433,000 $38.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.